2022
Influenza Antiviral Use in Patients Hospitalized With Laboratory-Confirmed Influenza in the United States, FluSurv-NET, 2015–2019
Tenforde M, Cummings C, O’Halloran A, Rothrock G, Kirley P, Alden N, Meek J, Yousey-Hindes K, Openo K, Anderson E, Monroe M, Kim S, Nunez V, McMahon M, McMullen C, Khanlian S, Spina N, Muse A, Gaitán M, Felsen C, Lung K, Shiltz E, Sutton M, Thomas A, Talbot H, Schaffner W, Price A, Chatelain R, Reed C, Garg S. Influenza Antiviral Use in Patients Hospitalized With Laboratory-Confirmed Influenza in the United States, FluSurv-NET, 2015–2019. Open Forum Infectious Diseases 2022, 10: ofac681. PMID: 36686630, PMCID: PMC9846184, DOI: 10.1093/ofid/ofac681.Peer-Reviewed Original Research
2018
Clinical Features and Outcomes of Immunocompromised Children Hospitalized With Laboratory-Confirmed Influenza in the United States, 2011–2015
Collins JP, Campbell AP, Openo K, Farley MM, Cummings CN, Kirley PD, Herlihy R, Yousey-Hindes K, Monroe ML, Ladisky M, Lynfield R, Baumbach J, Spina N, Bennett N, Billing L, Thomas A, Schaffner W, Price A, Garg S, Anderson EJ. Clinical Features and Outcomes of Immunocompromised Children Hospitalized With Laboratory-Confirmed Influenza in the United States, 2011–2015. Journal Of The Pediatric Infectious Diseases Society 2018, 8: 539-549. PMID: 30358877, DOI: 10.1093/jpids/piy101.Peer-Reviewed Original ResearchConceptsSolid organ transplantationImmunocompromised childrenClinical featuresImmunosuppressive therapyIntensive careOrgan transplantationInfluenza Hospitalization Surveillance NetworkHuman immunodeficiency virus/Community-acquired influenzaEarly antiviral treatmentLonger hospitalization durationDuration of hospitalizationIntensive care admissionAntiviral useCare admissionHospital deathHospitalization durationInfluenza vaccinationAntiviral treatmentInfluenza seasonInfluenza severityPrimary outcomeImmunodeficiency syndromeMultivariable analysisImmunoglobulin deficiency
2011
Description of Antiviral Treatment Among Adults Hospitalized With Influenza Before and During the 2009 Pandemic: United States, 2005–2009
Doshi S, Kamimoto L, Finelli L, Perez A, Reingold A, Gershman K, Yousey-Hindes K, Arnold K, Ryan P, Lynfield R, Morin C, Baumbach J, Hancock EB, Bennett NM, Zansky S, Thomas A, Schaffner W, Fry AM. Description of Antiviral Treatment Among Adults Hospitalized With Influenza Before and During the 2009 Pandemic: United States, 2005–2009. The Journal Of Infectious Diseases 2011, 204: 1848-1856. PMID: 22013219, DOI: 10.1093/infdis/jir648.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAmantadineAntiviral AgentsDrug Therapy, CombinationFemaleGuideline AdherenceHospitalizationHumansInfluenza A Virus, H1N1 SubtypeInfluenza, HumanMaleMiddle AgedOdds RatioOseltamivirPandemicsPractice Guidelines as TopicPractice Patterns, Physicians'PregnancyPregnancy Complications, InfectiousRimantadineUnited StatesYoung AdultZanamivirConceptsAntiviral treatmentPregnant womenHospitalized adultsActive population-based surveillanceEmerging Infections ProgramLaboratory-confirmed influenzaMedical record reviewPopulation-based surveillanceAntiviral recommendationsAntiviral useRecord reviewIllness onsetInfections ProgramInfluenza pandemicAntiviral agentsInfluenzaNegative predictorAdultsTreatmentWomenPandemicPatientsPregnancyCliniciansPersons